Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04749888Not ApplicableActive Not Recruiting

Impact of the Korea Early Childhood Home-visiting Intervention

Role: collaborator

NCT06089655Not ApplicableUnknown

Intervention Trial Using Artificial Intelligence(AI) Diet Application for Management of Diet in Diabetes Patients

Role: collaborator

NCT02792816Completed

Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar

Role: collaborator

NCT02708199Completed

Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody Kinetic

Role: collaborator

NCT02198573Completed

Molecular Assessment of Artemisinin Resistance Markers in Eastern and Western Border Areas of Myanmar

Role: collaborator

All 5 trials loaded